Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABBV-181 for HIV
Recruiting0 awardsPhase 1
Cincinnati, Ohio
This trial is testing a new drug called ABBV-181 in people with HIV who are stopping their usual treatment. The goal is to see if the drug is safe and effective, and how it affects the immune system and the virus.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service